The purpose of this study is to assess the use of a mobile health intervention to improve adherence to asthma medication among adolescents. The intervention consists of an inhaler sensor strap to monitor asthma inhaler use and a mobile phone application to remind and incentivize patients to use their medication. This study will assess medication use throughout the study in patients who receive a mobile app with reminders and asthma control as measured by the ACT [asthma control test].
Full Title of Study: “Pilot Study of a Mobile Intervention to Increase Adherence to Asthma Medication Among Adolescents”
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Treatment
- Masking: None (Open Label)
- Study Primary Completion Date: March 2015
- Device: Inhaler sensor
- Inhaler sensor strap that tracks inhaler use via a pressure sensitive switch.
- Behavioral: Mobile application for asthma adherence
- Mobile phone application that sends reminders, allows patients to see their medication use, and provides points and other incentives for medication use.
Arms, Groups and Cohorts
- Sham Comparator: Standard Care with Medication Monitoring
- Patients will be given an inhaler sensor to monitor medication use and a sham version of the mobile app that will not include reminders or incentives. Intervention: Inhaler sensor
- Experimental: Medication Monitoring and Mobile App
- Patients will be given an inhaler sensor to monitor medication use and a mobile phone application that will send them reminders and provide an opportunity to see their own medication use and win incentives for adherence. Interventions: Inhaler sensor and mobile application for asthma adherence
Clinical Trial Outcome Measures
- Real-time medication adherence in patients receiving reminders and incentives compared to standard care.
- Time Frame: 12 weeks
- Analysis of real-time medication use data in the experimental [app + sensor] arm vs the sensor only arm.
- Asthma control in patients receiving reminders and incentives compared to standard care (Analysis of the ACT [asthma control test])
- Time Frame: 12 weeks
- Analysis of the ACT [asthma control test] at baseline and follow up for patients in each arm to assess changes in asthma control with use of the mobile app.
Participating in This Clinical Trial
- Age 11-19
- Asthma diagnosis
- Currently on a daily controller HFA (hydrofluoroalkane) medication for Asthma
- Has a smartphone or access to a smartphone or tablet
- Foster Care
- Emancipated minor
Gender Eligibility: All
Minimum Age: 11 Years
Maximum Age: 19 Years
Are Healthy Volunteers Accepted: No
- Lead Sponsor
- Icahn School of Medicine at Mount Sinai
- Provider of Information About this Clinical Study
- Overall Official(s)
- Andrew M Ting, MD, Principal Investigator, Icahn School of Medicine at Mount Sinai
- Michael M Parides, PhD, Principal Investigator, Icahn School of Medicine at Mount Sinai
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.